from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0180c/-

LFCtreatmentdescriptionclass of inhibitor

-2.064

Amikacinug/mL Amikacintranslation

-0.678

Cap5-10ug/mL Capreomycintranslation

-1.228

Rox10-50 ug/mL Roxithromycintranslation

-0.516

SM2-5 ug/mL Streptomycintranslation

-3.725

Tet5-10 ug/mL Tetracyclinetranslation

-0.700

Rif0.2-5ug/mL Rifampicintranscription

-0.032

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.288

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.540

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.250

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.154

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.551

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.273

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

3.129

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.530

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.735

Nigericin50 uM Nigericinrespiration

0.054

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.361

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

-0.632

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.061

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.003

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.313

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.125

NRP_1Non-replicating persistence stage 1dosRassociated

0.135

Amp0.2mg/mL AmpicillincellWall

0.364

Cephalexin20-100 ug/mL CephalexincellWall

0.327

Cerulenin0.32-5 ug/mL CerulenincellWall

0.508

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.135

EMB10-20 ug/mL EthambutolcellWall

-0.006

Eta12-40 ug/mL EthionamidecellWall

-0.300

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.168

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.730

BZA0.12 mg/mL BenzamidearomaticAmides

0.559

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.302

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.316

H2O24 mM hydrogen peroxideDNAdamaging

0.379

Levo10 ug/mL LevofloxacinDNAdamaging

1.053

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.276

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.731

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.279

Antimycin12.5-50 ug/mL Antimycin A?

0.350

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.517

PA_110-50 ug/mL Antitubercular compound PA-1?

0.465

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.931

PA8240.2-2 ug/mL PA-824?

-1.311

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.653

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.154

Verapamil50 uM Verapamil?

-0.987

mercaptoethanol2 mM 2-Mercaptoethanol?

1.435

methoxatin10-20 ug/mL Methoxatin?